Literature DB >> 18349750

Control of renal uric acid excretion and gout.

Atsuo Taniguchi1, Naoyuki Kamatani.   

Abstract

PURPOSE OF REVIEW: Impaired renal uric acid excretion is the major mechanism of hyperuricemia in patients with primary gout. This review highlights recent advances in the knowledge of normal mechanisms of renal uric acid handling and derangement of these mechanisms in uric acid underexcretion. RECENT
FINDINGS: The discovery of URAT1 has facilitated identification of other molecules potentially involved in uric acid transport in the renal tubules. Some of these molecules show gender differential expression in animal experiments. Sodium-dependent monocarboxylate cotransporters have been shown to transport lactate and butyrate, and may have roles in hyperuricemia associated with diabetic ketoacidosis and alcohol ingestion. Certain polymorphisms in SLC22A12 may be associated with the development of hyperuricemia or gout, although confirmation is needed. Mechanisms of hyperuricemia associated with uric acid underexcretion in patients with familial juvenile hyperuricemic nephropathy also remain to be clarified. Distal tubular salt wasting and compensatory upregulation of the resorption of sodium and uric acid in the proximal tubule may explain the hyperuricemia associated with this disorder.
SUMMARY: Much progress has been made in understanding the mechanisms of renal uric acid handling. Elucidation of the mechanisms of hyperuricemia in patients with familial juvenile hyperuricemic nephropathy will shed light on the function of uromodulin, functional impairment of which eventually results in diminished uric acid excretion.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18349750     DOI: 10.1097/BOR.0b013e3282f33f87

Source DB:  PubMed          Journal:  Curr Opin Rheumatol        ISSN: 1040-8711            Impact factor:   5.006


  21 in total

1.  Genetic polymorphisms in the PDZK1 gene and susceptibility to gout in male Han Chinese: a case-control study.

Authors:  Ming Li; Qiang Li; Chang-Gui Li; Min Guo; Jin-Mei Xu; Ying-Ying Tang; Qing-Song Zhao; Yu-Hua Hu; Zhi-Feng Cheng; Jin-Chao Zhang
Journal:  Int J Clin Exp Med       Date:  2015-08-15

Review 2.  Fructose and uric acid in diabetic nephropathy.

Authors:  Petter Bjornstad; Miguel A Lanaspa; Takuji Ishimoto; Tomoki Kosugi; Shinji Kume; Diana Jalal; David M Maahs; Janet K Snell-Bergeon; Richard J Johnson; Takahiko Nakagawa
Journal:  Diabetologia       Date:  2015-06-07       Impact factor: 10.122

Review 3.  Recent advances in renal urate transport: characterization of candidate transporters indicated by genome-wide association studies.

Authors:  Naohiko Anzai; Promsuk Jutabha; Sirirat Amonpatumrat-Takahashi; Hiroyuki Sakurai
Journal:  Clin Exp Nephrol       Date:  2011-11-01       Impact factor: 2.801

4.  Influence of urate-lowering therapies on renal handling of uric acid.

Authors:  Lili Ma; Lei Wei; Huiyong Chen; Zhuojun Zhang; Qiang Yu; Zongfei Ji; Lindi Jiang
Journal:  Clin Rheumatol       Date:  2014-11-06       Impact factor: 2.980

5.  No evidence for involvement of the toll-like receptor (TLR) 4 gene Asp299Gly and Thr399Ile polymorphisms in susceptibility to primary gouty arthritis.

Authors:  Yu-Feng Qing; Jing-Guo Zhou; Ming Li; Wen-Guang Xie; Cui-Ping Huang; Sheng-Ping Zeng; Ling Yin
Journal:  Rheumatol Int       Date:  2012-11-15       Impact factor: 2.631

6.  Homozygous SLC2A9 mutations cause severe renal hypouricemia.

Authors:  Dganit Dinour; Nicola K Gray; Susan Campbell; Xinhua Shu; Lindsay Sawyer; William Richardson; Gideon Rechavi; Ninette Amariglio; Liat Ganon; Ben-Ami Sela; Hilla Bahat; Michael Goldman; Joshua Weissgarten; Michael R Millar; Alan F Wright; Eliezer J Holtzman
Journal:  J Am Soc Nephrol       Date:  2009-11-19       Impact factor: 10.121

7.  Association of three genetic loci with uric acid concentration and risk of gout: a genome-wide association study.

Authors:  Abbas Dehghan; Anna Köttgen; Qiong Yang; Shih-Jen Hwang; Wh Linda Kao; Fernando Rivadeneira; Eric Boerwinkle; Daniel Levy; Albert Hofman; Brad C Astor; Emelia J Benjamin; Cornelia M van Duijn; Jacqueline C Witteman; Josef Coresh; Caroline S Fox
Journal:  Lancet       Date:  2008-10-01       Impact factor: 79.321

8.  Changes in toll-like receptor (TLR)4-NFκB-IL1β signaling in male gout patients might be involved in the pathogenesis of primary gouty arthritis.

Authors:  Yu-Feng Qing; Quan-Bo Zhang; Jing-Guo Zhou; Li Jiang
Journal:  Rheumatol Int       Date:  2013-09-14       Impact factor: 2.631

9.  Monoamine oxidase A gene polymorphisms and enzyme activity associated with risk of gout in Taiwan aborigines.

Authors:  Hung-Pin Tu; Albert Min-Shan Ko; Shu-Jung Wang; Chien-Hung Lee; Rod A Lea; Shang-Lun Chiang; Hung-Che Chiang; Tsu-Nai Wang; Meng-Chuan Huang; Tsan-Teng Ou; Gau-Tyan Lin; Ying-Chin Ko
Journal:  Hum Genet       Date:  2009-11-14       Impact factor: 4.132

10.  IL-37 inhibits the production of pro-inflammatory cytokines in MSU crystal-induced inflammatory response.

Authors:  Mei Zeng; Wantai Dang; Baofeng Chen; Yufeng Qing; Wenguang Xie; Mingcai Zhao; Jingguo Zhou
Journal:  Clin Rheumatol       Date:  2015-11-07       Impact factor: 2.980

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.